Scolaris Content Display Scolaris Content Display

Self‐management for non‐cystic fibrosis bronchiectasis

Esta versión no es la más reciente

Referencias

Additional references

Aliberti 2016

Aliberti S, Masefield S, Polverino E, De Soyza A, Loebinger MR, Menendez R, et al. Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration. European Respiratory Journal 2016;48(3):632.47. [DOI: 10.1183/13993003.01888‐2015]

Bourbeau 2004

Bourbeau J, Nault D, Dang‐Tan T. Self‐management and behaviour modification in COPD. Patient Education and Counseling 2004;52(3):271‐7.

Challis 2010

Challis D, Hughes J, Berzins K, Reilly S, Abell J, Stewart K. Self‐care and case management in long‐term conditions: The effective management of critical interfaces. http://www.pssru.ac.uk/pdf/MCpdfs/SCCMfr.pdf Accessed 11th January 2017.

Chalmers 2012

Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT. Short‐ and long‐term antibiotic treatment reduces airway and systemic inflammation in non–cystic fibrosis bronchiectasis. American Journal of Respiratory and Critical Care Medicine 2012;186(7):657‐65.

Chalmers 2014

Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, et al. The Bronchiectasis Severity Index: an international derivation and validation study. American Journal of Respiratory and Critical Care Medicine 2014;189(5):576‐85. [DOI: 10.1164/rccm.201309‐1575OC]

Chalmers 2016

Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. Eur Respir J 2016;45(5):1446‐62.

Chang 2003

Chang AB, Masel JP, Boyce NC, Wheaton G, Torzillo PJ. Non‐CF bronchiectasis: clinical and HRCT evaluation. Pediatric Pulmonology 2003;35(6):477‐83. [DOI: 10.1002/ppul.10289]

Chang 2015

Chang AB, Bell SC, Torzillo PJ, King PT, Maguire GP, Byrnes CA, et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Medical Journal of Australia 2015; 202;202(1):21‐3. [DOI: 10.5694/mja14.00287]

Cole 1986

Cole PJ. Inflammation: a two‐edged sword—the model of bronchiectasis. European Journal of Respiratory Diseases Supplement 1986;147:6‐15.

de Silva 2011

de Silva D. Helping People Help Themselves. London: The Health Foundation, 2011.

Department of Health 2001

Department of Health. The Expert Patient: A New Approach to Chronic Disease Management for the 21st Century. London: Department of Health, 2001.

Effing 2012

Effing TW, Bourbeau J, Vercoulen J, Apter AJ, Coultas D, Meek P. Self‐management programmes for COPD: moving forward. Chronic Respiratory Disease 2012;9(1):27‐35.

Egger 1997

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34. [PUBMED: 9310563]

European Lung White Book 2013

Gibson GJ, Loddenkemper R, Sibille Y, Lundbäck B, editor(s). European Lung White Book: Respiratory Health and Disease in Europe. European Respiratory Society. www.erswhitebook.org.

Farrell 2004

Farrell K, Wicks MN, Martin JC. Chronic disease self‐management improved with enhanced self‐efficacy. Clinical Nursing Research 2004;13(4):289‐308.

Gewandter 2014

Gewandter JS, McDermott MP, McKeown A, Smith SM, Williams MR, Hunsinger M, et al. Reporting of missing data and methods used to accommodate them in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain 2014;155(9):1871‐7. [DOI: 10.1016/j.pain.2014.06.018]

Goeminne 2012

Goeminne PC, Scheers H, Decraene A, Seys S, Dupont LJ. Risk factors for morbidity and death in non‐cystic fibrosis bronchiectasis: a retrospective cross‐sectional analysis of CT diagnosed bronchiectatic patients. Respiratory Research 2012;13:21.

Goeminne 2016

Goeminne PC, De Soyza A. Bronchiectasis: how to be an orphan with many parents?. European Respiratory Journal 2016;47(1):10‐3.

GRADE 2014

Grade Working Group. Education and debate: grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490‐4. [DOI: 10.1136/bmj.328.7454.1490]

GRADEpro GDT [Computer program]

GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 28 April 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014.

Griffiths 2005

Griffiths C, Motlib J, Azad A, Ramsay J, Eldridge S, Feder G, et al. Randomised controlled trial of a lay‐led self management programme for Bangladeshi patients with chronic disease. British Journal of General Practice 2005;55(520):831‐7.

Habesoglu 2011

Habesoglu MA, Ugurlu AO, Eyuboglu FO. Clinical, radiological, and functional evaluation of 304 patients with bronchiectasis. Annals of Thoracic Medicine 2011;6(3):131‐6.

Hagger 2014

Hagger MS, Luszczynska A. Implementation intention and action planning interventions in health contexts: state of the research and proposals for the way forward. Applied Psychology: Health and Well‐Being 2014;6(1):1‐47.

Haworth 2014

Haworth CS, Foweraker JE, Wilkinson P, Kenyon RF, Bilton D. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. American Journal of Respiratory and Critical Care Medicine 2014;189(8):975‐82.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Kennedy 2013

Kennedy A, Peter P, Reeves D, Blakeman T, Bowen R, Chew‐Graham C, et al. Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trial. BMJ 2013;346:f2882. [doi: http://dx.doi.org/10.1136/bmj.f2882]

Kolbe 1996

Kolbe J, Wells AU. Bronchiectasis: a neglected cause of respiratory morbidity and mortality. Respirology 1996;1(4):221‐5.

Lavery 2007

Lavery K, O'Neill B, Elborn JS, Reilly J, Bradley JM. Self‐management in bronchiectasis: the patients’ perspective. European Respiratory Journal 2007;29(3):541‐7. [DOI: 10.1183/09031936.00057306]

Lefebvre 2011

Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Little 2012

Little RJ, D'Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, et al. The prevention and treatment of missing data in clinical trials. New England Journal of Medicine 2012;367(14):1355‐60. [DOI: 10.1056/NEJMsr1203730]

Lorig 2003

Lorig KR, Holman HR. Self‐management education: history, definition, outcomes, and mechanisms. Annals of Behavioral Medicine 2003;26(1):1‐7.

Martinez‐García 2007

Martinez‐García MA, Soler‐Cataluña JJ, Perpiñá‐Tordera M, Román‐Sánchez P, Soriano J. Factors associated with lung function decline in adult patients with stable non‐cystic fibrosis bronchiectasis. Chest 2007;132(5):1565‐72.

Martinez‐García 2014

Martinez‐García MA, de Gracia J, Vendrell Relat MV, Girón RM, Máiz Carro L, de la Rosa Carrillo D, et al. Multidimensional approach to non‐cystic fibrosis bronchiectasis: the FACED score. European Respiratory Journal 2014;43(5):1357‐67. [DOI: 10.1183/09031936.00026313]

McCullough 2014

McCullough AR, Tunney AM, Quittner A, Elborn J, Bradley J, Hughes C. Treatment adherence and health outcomes in patients with bronchiectasis. BMC Pulmonary Medicine 2014;14:107.

McCullough 2015

McCullough AR, Tunney MM, Elborn JS, Bradley JM, Hughes CM. Predictors of adherence to treatment in bronchiectasis. Respiratory Medicine 2015;109(7):838‐45.

Moher 2009

Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097]

Murray 2011

Murray M, Govan J, Doherty C, Simpson A, Wilkinson T, Chalmers J, et al. A randomized controlled trial of nebulized gentamicin in non–cystic fibrosis bronchiectasis. American Journal of Respiratory and Critical Care Medicine 2011;183(4):491‐9.

Naylor 2015

Naylor C, Imison C, Addicott R, Buck D, Goodwin N, Harrison T, et al. Transforming our health care system. https://www.kingsfund.org.uk/publications/articles/transforming‐our‐health‐care‐system‐ten‐priorities‐commissioners. London: Kings Fund, Accessed 11th January 2017. [http://www.kingsfund.org.uk/publications/articles/transforming‐our‐health‐care‐system‐ten‐priorities‐commissioners]

O'Brien 2000

O'Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterization of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000;55(8):635–42.

O'Neill 2016

O'Neill J. Tackling drug‐resistant infections globally: FInal report and recommendations. The review on antimicrobial resistance.. https://amr‐review.org/ Accessed 11th January 2017.

Pasteur 2000

Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. American Journal of Respiratory and Critical Care Medicine 2000;162(4 Pt 1):1277‐84.

Pasteur 2010

Pasteur MC, Bilton D, Hill AT, the British Thoracic Society Bronchiectasis (non‐CF) Guideline Group. British Thoracic Society Guidelines for non‐CF bronchiectasis. Thorax 2010;65(Suppl 1):i1‐i58.

Peytremann‐Bridevaux 2015

Peytremann‐Bridevaux I, Arditi C, Gex G, Bridevaux PO, Burnand B. Chronic disease management programmes for adults with asthma. Cochrane Database of Systematic Reviews 2015, Issue 5. [DOI: 10.1002/14651858.CD007988.pub2]

Quint 2016

Quint JK, Millett ERC, Joshi M, Navaratnam V, Thomas SL, Hurst JR, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population‐based cohort study. European Respiratory Journal 2016;47(1):186‐93. [DOI: 10.1183/13993003.01033‐2015]

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Roberts 2010

Roberts HJ, Hubbard R. Trends in bronchiectasis mortality in England and Wales. Respiratory Medicine 2010;104(7):981‐5.

Saleh 2014

Saleh AD, Hurst JR. How to assess the severity of bronchiectasis. European Respiratory Journal 2014;43(5):1217‐9. [DOI: 10.1183/09031936.00226913]

Savage 2014

Savage E, Beirne PV, Ni Chroinin M, Duff A, Fitzgerald T, Farrell D. Self‐management education for cystic fibrosis. Cochrane Database of Systematic Reviews 2014, Issue 9. [DOI: 10.1002/14651858.CD007641.pub3]

Sawicki 2009

Sawicki DS, Sellers DE, Robinson WM. High treatment burden in adults with cystic fibrosis: Challenges to disease self‐management. Journal of Cystic Fibrosis 2009;8(2):91‐6. [DOI: 10.1016/j.jcf.2008.09.007]

Seitz 2010

Seitz AE, Olivier KN, Steiner CA, Montes de Oca R, Holland SM, Prevots DR. Trends and burden of bronchiectasis‐associated hospitalizations in the United States. Chest 2010;138(4):944‐9.

Seitz 2012

Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots DR. Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000‐2007. Chest 2012;142(2):432‐9.

Singleton 2000

Singleton R, Morris A, Redding G, Poll J, Holck P, Martinez P, et al. Bronchiectasis in Alaska Native children: Causes and clinical courses. Pediatric Pulmonology 2000;29(3):182‐7.

Siu 2007

Siu AMH, Chan CCH, Poon PKK, Chui DYY, Chan SCC. Evaluation of the chronic disease management programme in a Chinese population. Patient Education and Counseling 2007;65(1):42‐50.

Taylor 2014

Taylor SJC, Pinnock H, Epiphaniou E, Pearce G, Parke HL, Schwappach A, et al. A rapid synthesis of the evidence on interventions supporting self‐management for people with long‐term conditions: PRISMS – Practical Systematic RevIew of Self‐Management Support for long‐term conditions. Health Services and Delivery Research 2014;2(53):1‐622.

Tunney 2013

Tunney M. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. American Journal of Respiratory and Critical Care Medicine 2013;187(10):1118‐26.

Twiss 2005

Twiss J, Metcalfe R, Edwards E, Byrnes C. New Zealand national incidence of bronchiectasis "too high" for a developed country. Archives of Diseases in Childhood 2005;90(7):737‐40. [DOI: 10.1136/adc.2004.066472]

Walters 2010

Walters JA, Turnock AC, Walters EH, Wood‐Baker R. Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2010, Issue 5. [DOI: 10.1002/14651858.CD005074.pub3]

Welsh 2015

Welsh EJ, Evans DJ, Fowler SJ, Spencer S. Interventions for bronchiectasis: an overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews 2015, Issue 7. [DOI: 10.1002/14651858.CD010337.pub2]

Weycker 2005

Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clinical Pulmonary Medicine 2005;12(4):205‐9.

Zwerink 2014

Zwerink M, Brusse‐Keizer M, van der Valk PD, Zielhuis GA, Monninkhof EM, van der Palen J, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2014, Issue 3. [DOI: 10.1002/14651858.CD002990.pub3]